Progestins in the medical management of active acromegaly.
D000172:Acromegaly / Q000188:drug therapy* / Q000532:radiotherapy; D001120:Arginine; D002277:Carcinoma / Q000139:chemically induced; D003864:Depression, Chemical; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005262:Feminization / Q000139:chemically induced; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism* / Q000502:physiology*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007118:Immunoassay; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008796:Metrorrhagia / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced
D004967:Estrogens; D013006:Growth Hormone; D001120:Arginine; D008525:Medroxyprogesterone